408 related articles for article (PubMed ID: 11655077)
1. Development of vaccines to meet public health needs: incentives and obstacles.
Russell PK
Risk; 1996; 7(3):239-52. PubMed ID: 11655077
[No Abstract] [Full Text] [Related]
2. Legal and regulatory perspectives in mass immunization programs.
Ladimer I
Insur Law J; 1976 Aug; (643):. PubMed ID: 11664613
[No Abstract] [Full Text] [Related]
3. RU 486 and the politics of drug regulation in the United States and France.
Kramnick RK
Cornell Int Law J; 1992; 25():667-718. PubMed ID: 11656340
[No Abstract] [Full Text] [Related]
4. The role of the federal government in protecting citizens from communicable diseases.
Morgenstern MS
Univ Cincinnati Law Rev; 1978; 47(4):537-71. PubMed ID: 11664964
[No Abstract] [Full Text] [Related]
5. Regulating biotechnology.
McGarity TO
Issues Sci Technol; 1985; 1(3):40-56. PubMed ID: 11649701
[No Abstract] [Full Text] [Related]
6. The exclusion from the United States of aliens infected with the AIDS virus: recent developments and prospects for the future.
Osuna JP
Houst J Int Law; 1993; 16(1):1-41. PubMed ID: 11652756
[No Abstract] [Full Text] [Related]
7. Immigration policies related to communicable diseases.
American Public Health Association
Am J Public Health; 1991 Feb; 81(2):249. PubMed ID: 11642862
[No Abstract] [Full Text] [Related]
8. Vaccines and the law.
Sanzo M
Pepperdine Law Rev; 1991 Dec; 19(1):29-48. PubMed ID: 11659523
[No Abstract] [Full Text] [Related]
9. Off the pedestal and into the arena: toward including women in experimental protocols.
Gorenberg H; White A
Rev Law Soc Change; 1991-1992; 19(1):205-46. PubMed ID: 11659599
[No Abstract] [Full Text] [Related]
10. American IRBs and Dutch research ethics committees: how they compare.
Bergkamp L
IRB; 1988; 10(5):1-6. PubMed ID: 11650072
[No Abstract] [Full Text] [Related]
11. Bioethics and tobacco.
Kahn J
Bioeth Exam; 1997; 1(3):1, 7. PubMed ID: 11656816
[No Abstract] [Full Text] [Related]
12. Will the USSR take genes to war?
Joyce C
New Sci; 1984 May; 102(1412):9. PubMed ID: 11655610
[No Abstract] [Full Text] [Related]
13. Patenting gene fragments.
Agrawal A
Econ Polit Wkly; 1993 May; 28(22):1089-93. PubMed ID: 11660270
[No Abstract] [Full Text] [Related]
14. Reagan signs bill on drug exports and payment for vaccine injuries.
Pear R
N Y Times Web; 1986 Nov; ():1, 9. PubMed ID: 11647821
[No Abstract] [Full Text] [Related]
15. FDA issues concerning conflicts of interest.
Kurt TL
IRB; 1990; 12(5):6-9. PubMed ID: 11654003
[No Abstract] [Full Text] [Related]
16. Regulation of genetic engineering: less concern about Frankensteins but time for action on commercial production.
Karny GM
Univ Toledo Law Rev; 1981; 12(4):815-68. PubMed ID: 11649588
[No Abstract] [Full Text] [Related]
17. AIDS-based discrimination in the workplace: issues and answers.
Kussner B
Univ Tor Fac Law Rev; 1989; 47(2):383-419. PubMed ID: 11652617
[No Abstract] [Full Text] [Related]
18. Ethical considerations in the patenting of medical processes.
Burch GF
Tex Law Rev; 1987 May; 65(6):1139-71. PubMed ID: 11649961
[No Abstract] [Full Text] [Related]
19. Bioethics and applied biomaterials.
Saha S; Saha P
J Biomed Mater Res; 1987 Aug; 21(Suppl. A2):181-90. PubMed ID: 11649924
[No Abstract] [Full Text] [Related]
20. AIDS and drug pricing: in search of a policy.
Salbu SR
Wash Univ Law Q; 1993; 71(3):691-734. PubMed ID: 11652750
[No Abstract] [Full Text] [Related]
[Next] [New Search]
